Menu
Insurance Coverage Guide

Does UnitedHealthcare Cover Prolotherapy? (2026 Guide)

UnitedHealthcare coverage guide for prolotherapy (dextrose injections) for joint pain. Learn what's covered, typical costs ($200-$600 per session (typically 3-6 sessions needed)), requirements, and how to handle denials.

Medically Reviewed by Medical Review Team, MD

Important: Coverage information is subject to change. Always verify current coverage with your insurance provider or Medicare.gov before making healthcare decisions.

Disclaimer: Joint Pain Authority is not affiliated with, endorsed by, or part of Medicare, the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Health and Human Services, or any government agency. Information provided is for educational purposes only and should not be considered medical or insurance advice.

Quick Coverage Summary

prolotherapy

✗ Not Covered

The vast majority of private insurers do NOT cover prolotherapy. BCBS, Aetna, UHC, Cigna, and Humana all classify prolotherapy as experimental/investigational. Rare exceptions exist for Workers' Compe

Quick Answer

UnitedHealthcare does NOT typically cover prolotherapy for joint pain and arthritis. This treatment is classified as experimental, not medically necessary, or falls outside standard insurance benefit categories. Patients typically pay out of pocket. Expect to pay $200-$600 per session (typically 3-6 sessions needed) out of pocket.

What Is Prolotherapy?

Prolotherapy (proliferative therapy) involves injecting a sugar solution (usually dextrose) into damaged ligaments, tendons, or joint spaces. The mild irritant triggers a localized inflammatory response, theoretically stimulating the body’s natural healing and tissue repair processes.

The Coverage Reality

Prolotherapy is not covered by Medicare or the vast majority of private insurance plans. This has been the case for decades, and coverage is unlikely to change in the near future because:

  1. CMS exclusion: Medicare has specifically excluded prolotherapy since the 1990s
  2. Evidence threshold: Most insurers require stronger RCT evidence than currently exists
  3. Professional society support: AAOS and ACR do not endorse prolotherapy for osteoarthritis
  4. Coding challenges: No specific CPT code exists; must use generic injection codes

What the Evidence Shows

StudyFindingLimitation
Rabago 2013 (Annals of Family Medicine)Dextrose prolotherapy improved WOMAC scores vs saline and exercise at 1 yearSmall sample (n=90), single-center
Sit 2020 meta-analysisModerate evidence for knee OA pain reductionHigh heterogeneity between studies
Cochrane 2024 reviewInsufficient evidence to recommend or rejectCalled for larger, better-designed trials

Cost and Payment Options

Since insurance doesn’t cover prolotherapy, here are realistic cost expectations:

ComponentCost
Initial consultation$150-$300
Per injection session$200-$600
Typical course (4-6 sessions)$800-$3,600 total
Follow-up visits$75-$150 each

Ways to manage the cost:

  1. HSA/FSA funds — may be reimbursable with a Letter of Medical Necessity
  2. Payment plans — many prolotherapy practitioners offer monthly payment options
  3. Package pricing — some clinics offer discounts for prepaid multi-session packages

Covered Alternatives to Consider

If prolotherapy’s out-of-pocket cost is a barrier, these treatments target similar conditions and ARE typically covered by insurance:


UnitedHealthcare-Specific Coverage Details

Status: Generally Not Covered

The vast majority of private insurers do NOT cover prolotherapy. BCBS, Aetna, UHC, Cigna, and Humana all classify prolotherapy as experimental/investigational. Rare exceptions exist for Workers’ Compensation claims in some states. Cash-pay pricing is typically $200-$600 per session.

Why Coverage Is Denied

  • Classified as experimental/investigational by insurer
  • Not supported by sufficient clinical evidence per payer medical policy
  • No CPT code specific to prolotherapy (billed under generic injection codes)
  • AAOS and most professional societies do not endorse prolotherapy for OA

Alternative Payment Options

  • Prolotherapy appeals have very low success rates with most insurers
  • Document extensive failed conservative treatment history
  • Include peer-reviewed research (Rabago 2013 knee OA trial)
  • Consider HSA/FSA reimbursement as an alternative to insurance coverage
  • Some practitioners offer payment plans for out-of-pocket costs

Appeal Tips

  • Prolotherapy appeals have very low success rates with most insurers
  • Document extensive failed conservative treatment history
  • Include peer-reviewed research (Rabago 2013 knee OA trial)
  • Consider HSA/FSA reimbursement as an alternative to insurance coverage
  • Some practitioners offer payment plans for out-of-pocket costs

Stay ahead of joint pain

Get weekly insights on joint health and pain relief delivered to your inbox.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

Check Your Insurance Eligibility

Use our free tool to find out what joint pain treatments your insurance may cover.

Check Eligibility

Stay ahead of joint pain

Get weekly insights on joint health and pain relief delivered to your inbox.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

More Insurance Guides

Learn about coverage from different insurance providers and plans.

View all insurance guides